BioCentury
ARTICLE | Company News

Onyx names Fuchs CMO

September 19, 2005 11:53 PM UTC

ONXX hired Henry Fuchs as EVP and CMO. Previously, Fuchs was CEO at IntraBiotics (IBPI). ONXX's Sorafenib ( BAY 43-9006) is under FDA review with an undisclosed PDUFA date. Earlier this month, ONXX an...